Nivedita Namdev

Asymmetric Catalysis of the Strecker Amino Acid Synthesis by a Cyclic Dipeptide

Mani S. Iyer, Kenneth M. Gigstad, Nivedita Namdev et al. · Journal of the American Chemical Society · 1996 · 339 citations

Diversity Oriented Synthesis, Biochemistry, Donut Icon +12

Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor

Jean‐Marc Lapierre, Sudharshan Eathiraj, David Vensel et al. · Journal of Medicinal Chemistry · 2016 · 105 citations · Full text

Pharmaceutical Science, Pharmacotherapy, Pharmaceutical Chemistry +18

Discovery and Optimization of a Series of 3-(3-Phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amines: Orally Bioavailable, Selective, and Potent ATP-Independent Akt Inhibitors

Mark A. Ashwell, Jean‐Marc Lapierre, Christopher J. Brassard et al. · Journal of Medicinal Chemistry · 2012 · 98 citations · Full text

Chemical Biology, Pharmaceutical Chemistry, Biophysical Screening Strategy +19

Asymmetric catalysis of the Strecker amino acid synthesis by a cyclic dipeptide

Mani S. Iyer, Kenneth M. Gigstad, Nivedita Namdev et al. · Amino Acids · 1996 · 46 citations

Biochemistry, Natural Sciences, Biocatalysis +6

The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survival

Urszula L. McClurg, Mahsa Azizyan, Daniel T. Dransfield et al. · Oncotarget · 2018 · 31 citations · Full text

Androgen Receptor, Urology, Endocrine-related Cancer +11